Nitric oxide and arterial disease
Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been int...
Gespeichert in:
Veröffentlicht in: | Journal of Vascular Surgery 2004-07, Vol.40 (1), p.187-193 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 193 |
---|---|
container_issue | 1 |
container_start_page | 187 |
container_title | Journal of Vascular Surgery |
container_volume | 40 |
creator | Barbato, Joel E. Tzeng, Edith |
description | Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been intensively investigated and further elucidated over the past two decades. It is important in the pathogenesis of many cardiovascular diseases, including atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been used as a therapeutic tool to treat diseases that range from recurrent stenosis to inhibiting thrombotic events. Many commonly used medications have their therapeutic actions through the production of NO. This review highlights the vascular biologic characteristics of NO, its role in the pathogenesis of cardiovascular disease processes, and its potential therapeutic applications. |
doi_str_mv | 10.1016/j.jvs.2004.03.043 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66653363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521404005026</els_id><sourcerecordid>66653363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-2bd71f71908f4a853b27e97a3b00b2c6996ebff4973a8facfb3486de709a93513</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMozjj6A9zIuNBd602T5oErGXzBoBtdhzS9gZROOyYd0X9vhxnQlasLh-8cLh8h5xRyClTcNHnzmfICgOfAcuDsgEwpaJkJBfqQTEFympUF5RNyklIDQGmp5DGZ0DFUXJVTcvkShhjcvP8KNc5tV89tHDAG287rkNAmPCVH3rYJz_Z3Rt4f7t8WT9ny9fF5cbfMHC-KISuqWlIvqQbluVUlqwqJWlpWAVSFE1oLrLznWjKrvHW-YlyJGiVoq1lJ2Yxc73bXsf_YYBrMKiSHbWs77DfJCCFKxgQbQboDXexTiujNOoaVjd-Ggtl6MY0ZvZitFwPMjF7GzsV-fFOtsP5t7EWMwNUesMnZ1kfbuZD-cJoWpVIjd7vjcFTxGTCa5AJ2DusQ0Q2m7sM_b_wA4kd-Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66653363</pqid></control><display><type>article</type><title>Nitric oxide and arterial disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>EZB*</source><creator>Barbato, Joel E. ; Tzeng, Edith</creator><creatorcontrib>Barbato, Joel E. ; Tzeng, Edith</creatorcontrib><description>Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been intensively investigated and further elucidated over the past two decades. It is important in the pathogenesis of many cardiovascular diseases, including atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been used as a therapeutic tool to treat diseases that range from recurrent stenosis to inhibiting thrombotic events. Many commonly used medications have their therapeutic actions through the production of NO. This review highlights the vascular biologic characteristics of NO, its role in the pathogenesis of cardiovascular disease processes, and its potential therapeutic applications.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2004.03.043</identifier><identifier>PMID: 15218485</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Animals ; Biological and medical sciences ; Cardiovascular Diseases - metabolism ; Cardiovascular Diseases - physiopathology ; Humans ; Hyperplasia ; Medical sciences ; Neovascularization, Physiologic - drug effects ; Nitric Oxide - metabolism ; Nitric Oxide - physiology ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Thrombosis - physiopathology ; Tunica Intima - pathology ; Tunica Intima - physiopathology ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><ispartof>Journal of Vascular Surgery, 2004-07, Vol.40 (1), p.187-193</ispartof><rights>2004 The Society for Vascular Surgery</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-2bd71f71908f4a853b27e97a3b00b2c6996ebff4973a8facfb3486de709a93513</citedby><cites>FETCH-LOGICAL-c422t-2bd71f71908f4a853b27e97a3b00b2c6996ebff4973a8facfb3486de709a93513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0741521404005026$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>313,314,776,780,788,3537,27899,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15912588$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15218485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barbato, Joel E.</creatorcontrib><creatorcontrib>Tzeng, Edith</creatorcontrib><title>Nitric oxide and arterial disease</title><title>Journal of Vascular Surgery</title><addtitle>J Vasc Surg</addtitle><description>Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been intensively investigated and further elucidated over the past two decades. It is important in the pathogenesis of many cardiovascular diseases, including atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been used as a therapeutic tool to treat diseases that range from recurrent stenosis to inhibiting thrombotic events. Many commonly used medications have their therapeutic actions through the production of NO. This review highlights the vascular biologic characteristics of NO, its role in the pathogenesis of cardiovascular disease processes, and its potential therapeutic applications.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular Diseases - metabolism</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Medical sciences</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide - physiology</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Thrombosis - physiopathology</subject><subject>Tunica Intima - pathology</subject><subject>Tunica Intima - physiopathology</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMozjj6A9zIuNBd602T5oErGXzBoBtdhzS9gZROOyYd0X9vhxnQlasLh-8cLh8h5xRyClTcNHnzmfICgOfAcuDsgEwpaJkJBfqQTEFympUF5RNyklIDQGmp5DGZ0DFUXJVTcvkShhjcvP8KNc5tV89tHDAG287rkNAmPCVH3rYJz_Z3Rt4f7t8WT9ny9fF5cbfMHC-KISuqWlIvqQbluVUlqwqJWlpWAVSFE1oLrLznWjKrvHW-YlyJGiVoq1lJ2Yxc73bXsf_YYBrMKiSHbWs77DfJCCFKxgQbQboDXexTiujNOoaVjd-Ggtl6MY0ZvZitFwPMjF7GzsV-fFOtsP5t7EWMwNUesMnZ1kfbuZD-cJoWpVIjd7vjcFTxGTCa5AJ2DusQ0Q2m7sM_b_wA4kd-Rg</recordid><startdate>20040701</startdate><enddate>20040701</enddate><creator>Barbato, Joel E.</creator><creator>Tzeng, Edith</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040701</creationdate><title>Nitric oxide and arterial disease</title><author>Barbato, Joel E. ; Tzeng, Edith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-2bd71f71908f4a853b27e97a3b00b2c6996ebff4973a8facfb3486de709a93513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular Diseases - metabolism</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Medical sciences</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide - physiology</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Thrombosis - physiopathology</topic><topic>Tunica Intima - pathology</topic><topic>Tunica Intima - physiopathology</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barbato, Joel E.</creatorcontrib><creatorcontrib>Tzeng, Edith</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Vascular Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barbato, Joel E.</au><au>Tzeng, Edith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitric oxide and arterial disease</atitle><jtitle>Journal of Vascular Surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2004-07-01</date><risdate>2004</risdate><volume>40</volume><issue>1</issue><spage>187</spage><epage>193</epage><pages>187-193</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been intensively investigated and further elucidated over the past two decades. It is important in the pathogenesis of many cardiovascular diseases, including atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been used as a therapeutic tool to treat diseases that range from recurrent stenosis to inhibiting thrombotic events. Many commonly used medications have their therapeutic actions through the production of NO. This review highlights the vascular biologic characteristics of NO, its role in the pathogenesis of cardiovascular disease processes, and its potential therapeutic applications.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>15218485</pmid><doi>10.1016/j.jvs.2004.03.043</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5214 |
ispartof | Journal of Vascular Surgery, 2004-07, Vol.40 (1), p.187-193 |
issn | 0741-5214 1097-6809 |
language | eng |
recordid | cdi_proquest_miscellaneous_66653363 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; EZB* |
subjects | Animals Biological and medical sciences Cardiovascular Diseases - metabolism Cardiovascular Diseases - physiopathology Humans Hyperplasia Medical sciences Neovascularization, Physiologic - drug effects Nitric Oxide - metabolism Nitric Oxide - physiology Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Thrombosis - physiopathology Tunica Intima - pathology Tunica Intima - physiopathology Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels |
title | Nitric oxide and arterial disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T20%3A00%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitric%20oxide%20and%20arterial%20disease&rft.jtitle=Journal%20of%20Vascular%20Surgery&rft.au=Barbato,%20Joel%20E.&rft.date=2004-07-01&rft.volume=40&rft.issue=1&rft.spage=187&rft.epage=193&rft.pages=187-193&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2004.03.043&rft_dat=%3Cproquest_cross%3E66653363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66653363&rft_id=info:pmid/15218485&rft_els_id=S0741521404005026&rfr_iscdi=true |